Skip to content

Enovis ENOV Prevention & Recovery — Total Assets

Other segment segments

Reconstructive
$2.38B-19.9%

Similar metrics at other companies

Select Medical Holdings logo
SEMRehabilitation Hospital — Total Assets
$1.67B+18.7%
Select Medical Holdings logo
SEMOutpatient Rehabilitation — Total Assets
$1.4B-1.3%
nVent Electric plc logo
NVTSystems Protection — Total Assets
$3.5B+60.1%
Clorox logo
CLXHealth and Wellness — Total Assets
$1.2B
Huntsman logo
HUNPerformance Products — Total Assets
$1.18B
Select Medical Holdings logo
SEMCritical Illness Recovery Hospital — Total Assets
$2.8B+3.8%

Other financials

Income statement

See full
Revenue$589.2M+5.4%
Gross profit$365.5M+10.0%
Operating income$6.5M+114%
Net income-$8.8M+84.3%
EPS (diluted)-$0.15+84.7%

Balance sheet

See full
Cash & equivalents$33.1M-13.9%
Total debt$1.4B-3.1%
Total equity$1.5B-43.6%
Total assets$3.8B-21.4%

Cash flow

See full
Operating cash flow$24.0M+1,601%
CapEx$52.8M+22.1%
Free cash flow-$28.9M+35.7%

Valuation

See full
Market cap$1.23B-28.4%
Enterprise value$2.55B-17.1%
P/S0.5×-0.3×

Profitability

See full
Gross margin60.5%+4.0pp
Operating margin-47%+18.6pp
Net margin-49.9%+24.1pp
FCF margin-3.1%-1.1pp

Returns & leverage

See full
Return on equity-55.5%-1,722pp
Debt / equity0.9×+0.4×
Current ratio-0.5×

Where this comes from

Reported directly by Enovis in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Enovis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Enovis's prevention & recovery — total assets.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Enovis's prevention & recovery — total assets?
Enovis (ENOV) reported prevention & recovery — total assets of $1.45B in Q1 2026.
What does prevention & recovery — total assets mean?
This metric represents the total book value of resources, including inventory, property, plant, and equipment, controlled by the Prevention & Recovery segment. It quantifies the capital base deployed to support the development and distribution of medical devices for rehabilitation and pain management. Tracking this allows for the calculation of asset turnover and return on assets to determine how effectively the segment utilizes its resources to drive growth.